Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Gives Up 40 Points. More details...
CBT 200 Off Almost 50 Points. More details...
Development Stage Biotech Is Well-Received. More details...
CBT 200 Drops 11 Points. More details...
CBT 200 Gains 14 Points. More details...
CBT 200 Adds on 1%. More details...
CBT 200 Closes Up 1.8%. More details...
CBT 200 Loses 12 Points. More details...
Advance Is Broad And Deep. More details...
Glaxo Seeks Approval For Leukemia Drug. More details...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here